| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 87.29▲ | 88.42▼ | 88.82▼ | 88.36▼ | 92.17▼ |
| MA10 | 87.57▼ | 89.26▼ | 89.65▼ | 89.64▼ | 96.96▼ |
| MA20 | 88.11▼ | 89.82▼ | 88.04▼ | 92.09▼ | 101.32▼ |
| MA50 | 89.08▼ | 88.25▼ | 88.53▼ | 99.01▼ | 90.25▼ |
| MA100 | 90.24▼ | 88.74▼ | 90.04▼ | 102.67▼ | 70.22▲ |
| MA200 | 88.55▼ | 90.24▼ | 94.47▼ | 96.18▼ | 47.97▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.051▼ | -0.439▼ | -0.035▼ | -0.086▼ | -3.098▼ |
| RSI | 39.729▼ | 41.643▼ | 44.750▼ | 40.432▼ | 39.148▼ |
| STOCH | 21.016 | 7.277▼ | 18.713▼ | 45.927 | 16.970▼ |
| WILL %R | -70.696 | -93.827▼ | -78.049▼ | -69.722 | -84.129▼ |
| CCI | -78.443 | -121.299▼ | -72.025 | 49.907 | -122.225▼ |
|
Sunday, March 22, 2026 12:01 AM
Rhythm Pharmaceuticals (NASDAQ:RYTM) reported Phase 3 top-line results from its EMANATE trial evaluating setmelanotide in four heterozygous genetic cohorts linked to MC4R pathway dysfunction, with com ...
|
|
Saturday, March 21, 2026 01:37 AM
Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.
|
|
Friday, March 20, 2026 11:31 PM
Detailed price information for Rhythm Pharmaceuticals Inc (RYTM-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/03/26 | 97.25 | 100.00 | 86.535 | 87.45 | 3,062,969 |
| 19/03/26 | 84.71 | 90.53 | 84.00 | 90.31 | 993,720 |
| 18/03/26 | 86.21 | 87.255 | 84.02 | 85.86 | 845,910 |
| 17/03/26 | 89.29 | 91.05 | 86.805 | 87.68 | 1,029,711 |
| 16/03/26 | 88.55 | 91.28 | 87.00 | 90.51 | 770,482 |
| 13/03/26 | 88.84 | 90.50 | 82.00 | 87.38 | 1,620,513 |
| 12/03/26 | 88.81 | 92.69 | 88.00 | 91.15 | 639,480 |
| 11/03/26 | 91.77 | 93.88 | 88.74 | 90.02 | 583,935 |
| 10/03/26 | 93.51 | 94.94 | 92.075 | 93.01 | 472,674 |
| 09/03/26 | 94.27 | 94.93 | 90.55 | 93.00 | 607,858 |
|
|
||||
|
|
||||
|
|